Scarica l'app Stockscreener
4.02
0.25%
-0.01
Aquestive Therapeutics Inc Borsa (AQST) Ultime notizie
Aquestive Therapeutics, Inc. (NASDAQ:AQST) Q4 2025 earnings call transcript - MSN
What’s the RSI of Aquestive Therapeutics Inc. stockJuly 2025 Gainers & Safe Entry Momentum Stock Tips - mfd.ru
FinancialContentAQST UPCOMING DEADLINE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 - FinancialContent
ROSEN Law Firm Encourages Aquestive Therapeutics Investors to Secure Counsel Before Deadline - National Today
ROSEN, A HIGHLY RANKED LAW FIRM, Encourages Nektar Therapeutics Investors to Secure Counsel Before Important Deadline in Securities Class Action - GlobeNewswire Inc.
ROSEN, SKILLED INVESTOR COUNSEL, Encourages Enphase Energy, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – ENPH - GlobeNewswire Inc.
ROSEN, A RANKED AND LEADING LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to ... - Bluefield Daily Telegraph
Aquestive Therapeutics SVP Cioffi sells $105k in shares - Investing.com Nigeria
AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
2026-03-13 | AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AQST | Press Release - Stockhouse
Aquestive Therapeutics: Post-CRL Risk, Timeline, And Valuation (NASDAQ:AQST) - Seeking Alpha
AQST Investors Have Opportunity to Lead Aquestive Therapeutics, Inc. Securities Fraud Lawsuit - Sahm
AQST INVESTOR NOTICE: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026 - Sahm
Class Action Lawsuit Filed Against Aquestive Therapeutics - Intellectia AI
INVESTOR ALERT: Pomerantz Law Firm Reminds Investors with Losses on their Investment in Aquestive Therapeutics, Inc. of Class Action Lawsuit and Upcoming DeadlinesAQST - PR Newswire
Aquestive Therapeutics Investors Eligible for Securities Fraud Lawsuit - National Today
Bronstein, Gewirtz & Grossman LLC Urges Aquestive - GlobeNewswire
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT Bernstein Liebhard LLP Reminds Aquestive ... - Bluefield Daily Telegraph
AQUESTIVE THERAPEUTICS, INC. (AQST) SHAREHOLDER ALERT - GlobeNewswire
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Stockholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Aquestive therapeutics chief legal officer Braender sells $167k in stock - Investing.com Canada
Portnoy Law Firm Announces Class Action on Behalf of Aquestive Therapeutics, Inc. Investors - Carroll County Mirror-Democrat
Aquestive Therapeutics SVP Cioffi sells $105k in shares By Investing.com - Investing.com Canada
Aquestive Therapeutics CEO Barber sells $753,965 in stock By Investing.com - Investing.com Canada
Aquestive Therapeutics CEO Barber sells $753,965 in stock - Investing.com
Insider Selling: Aquestive Therapeutics (NASDAQ:AQST) COO Sells 45,791 Shares of Stock - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Insider Peter Boyd Sells 29,814 Shares - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) SVP Melina Cioffi Sells 25,311 Shares - MarketBeat
Insider Selling: Aquestive Therapeutics (NASDAQ:AQST) CFO Sells 58,254 Shares of Stock - MarketBeat
Aquestive Therapeutics (NASDAQ:AQST) Insider Lori Braender Sells 40,102 Shares - MarketBeat
Insider Selling: Aquestive Therapeutics (NASDAQ:AQST) CEO Sells 180,677 Shares of Stock - MarketBeat
Aquestive (AQST) CCO granted stock and options, sells shares to cover taxes - Stock Titan
Aquestive Therapeutics (AQST) COO reports equity grants and tax sale - Stock Titan
Aquestive (NASDAQ: AQST) CDO receives 50,000-share stock and option grants - Stock Titan
AQST Investors Encouraged to Seek Lead Plaintiff Role in Aquestive Therapeutics Securities Class Action Case with Johnson Fistel - lincolnjournal.com
Aquestive Therapeutics (AQST) CMO discloses 2,000 indirectly held shares on Form 3 - Stock Titan
AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Shareholders with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
HC Wainwright Issues Optimistic Forecast for AQST Earnings - MarketBeat
Aquestive Therapeutics: With Some Hiccups, Anaphylm Is Closer To FDA Approval - Seeking Alpha
Aquestive Therapeutics Targets Q3 Anaphylm Resubmission After FDA CRL Flags Human Factors, PK Data - MarketBeat
AQUESTIVE THERAPEUTICS, INC. (AQST) DEADLINE ALERT Bernstein Liebhard LLP Reminds Aquestive Therapeutics, Inc. Investors of Upcoming Deadline - ACCESS Newswire
ROSEN, A TOP RANKED LAW FIRM, Encourages Aquestive Therapeutics, Inc. Investors to Secure ... - Bluefield Daily Telegraph
ROSEN, A TOP RANKED LAW FIRM, Encourages Aquestive - GlobeNewswire
Rosen Law Firm Urges Aquestive Therapeutics, Inc. (NASDAQ: AQST) Stockholders to Contact the Firm for Information About Their Rights - The Joplin Globe
AQST Investor Alert: AQUESTIVE THERAPEUTICS, INC. Securities Fraud LawsuitInvestors With Losses May Seek to Lead the Class Action After Claims CEO Allegedly Misrepresented Company Prospects: Levi & Korsinsky - ChartMill
AQST INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics Investors of Securities Class Action Deadline on May 4, 2026 - TMX Newsfile
Class Action Filed Against Aquestive Therapeutics, Inc. (AQST) S - GuruFocus
AQST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire
Class Action Filed Against Aquestive Therapeutics, Inc. (AQST) Seeking Recovery for InvestorsContact The Gross Law Firm - Barchart.com
Oppenheimer Reaffirms Their Buy Rating on Aquestive Therapeutics (AQST) - The Globe and Mail
SHAREHOLDER ALERT Bernstein Liebhard LLP Announces A - GlobeNewswire
2026-03-10 | AQST STOCKHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AQST | Press Release - Stockhouse
What is HC Wainwright's Estimate for AQST FY2027 Earnings? - MarketBeat
Aquestive Therapeutics Targets Q3 Anaphylm FDA Resubmission After CRL, Details Launch Plans at Leerink Conf - MarketBeat
Aquestive Therapeutics Announces Grant of Inducement Award Pursuant to Nasdaq Listing Rule 5635(c)(4) - The Manila Times
Contact Levi & Korsinsky by May 4, 2026 Deadline to Join Class Action Against Aquestive Therapeutics, Inc.(AQST) - GlobeNewswire
AQST Class Action Notice: Robbins LLP Reminds Investors of - GlobeNewswire
2026-03-09 | AQST SHAREHOLDER ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AQST | Press Release - Stockhouse
Aquestive Therapeutics Maps Risky Path to ANNAFILM Launch - TipRanks
Market Review: Will Aquestive Therapeutics Inc benefit from government policyGlobal Markets & Stepwise Trade Signal Implementation - baoquankhu1.vn
AQST DEADLINE ALERT: Faruqi & Faruqi, LLP Reminds Aquestive Therapeutics (AQST) Investors of Securities Class Action Deadline on May 4, 2026 (2026-03-08) - Seeking Alpha
2026-03-08 | AQST INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Aquestive Therapeutics, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! | NDAQ:AQST | Press Release - Stockhouse
1.15%
3.21%
Apri su Yahoo
|
Apri su Google
|
Aperto in Finviz
|
Apri in MarketWatch
|
Aperto a EDGAR
|
Aperto su Reuters
Capitalizzazione:
|
Volume (24 ore):